---
figid: PMC7137211__13058_2020_1271_Fig1_HTML
figtitle: PI3K/AKT/mTOR axis and its alterations in breast cancer
organisms:
- Homo sapiens
- unidentified
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7137211
filename: 13058_2020_1271_Fig1_HTML.jpg
figlink: pmc/articles/PMC7137211/figure/Fig1/
number: F1
caption: Schematic representation of the PI3K/AKT/mTOR axis and its alterations in
  breast cancer. Alpelisib selectively inhibits the p110α subunit of PI3K, which is
  mutated and constitutively activated in approximately 40% of HR+ HER2− BC
papertitle: 'Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative
  breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different
  clinical implications.'
reftext: Claudio Vernieri, et al. Breast Cancer Res. 2020;22:33.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9612437
figid_alias: PMC7137211__F1
figtype: Figure
redirect_from: /figures/PMC7137211__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7137211__13058_2020_1271_Fig1_HTML.html
  '@type': Dataset
  description: Schematic representation of the PI3K/AKT/mTOR axis and its alterations
    in breast cancer. Alpelisib selectively inhibits the p110α subunit of PI3K, which
    is mutated and constitutively activated in approximately 40% of HR+ HER2− BC
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FCGR1A
  - FCGR1BP
  - FCGR1CP
  - FGFR1
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - PDK1
  - PDPK1
  - STK11
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - TSC2
  - ACACA
  - BCL2A1
  - MTOR
  - RPTOR
  - EIF4EBP1
  - RPS6KB1
  - ESR1
  - ERAL1
  - bnl
  - InR
  - btl
  - Oamb
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Akt
  - Pdk1
  - Lkb1
  - SNF4Agamma
  - AMPKalpha
  - gig
  - Crtc
  - Thor
  - S6k
  - era
---
